Abstract:Objective To investigate the clinical value and adverse reactions of peramivir sodium chloride injection in the treatment of emergency nonsevere influenza.Methods Two hundred and sixtyfive cases of severe acute influenza were diagnosed and treated in isolation. According to the numerical table method, 132 patients in the control group were randomly divided into the observation group and 133 patients in the observation group. The course of treatment is one week. After 3 days and 1 week of treatment, the data changes of fever, cough, pharyngeal pain and headache in the two groups were compared, and the clinical efficacy was observed. Results After 3 and 7 days of treatment, fever, cough, sore throat and headache in the observation group were relieved and disappeared better than those in the control group (P<0.05). The total effective rate of the observation group (92.48%) was significantly higher than that of the control group (84.85%) (P<0.05). The rate of severe patients in the observation group (0%) was significantly lower than that in the control group (2.3%)(P<0.05). There were no adverse reactions in both groups.Conclusion The efficacy of pramivir in the treatment of emergency non severe influenza is significant, it can reduce complications, reduce the rate of severe patients, and can be widely used in clinical practice.
